SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by Transamerica Financial Advisors Inc.

Transamerica Financial Advisors Inc. trimmed its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 21.9% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 5,465 shares of the exchange traded fund’s stock after selling 1,532 shares during the period. Transamerica Financial Advisors Inc.’s holdings in SPDR S&P Biotech ETF were worth $493,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of the company. Golden State Wealth Management LLC purchased a new stake in shares of SPDR S&P Biotech ETF during the fourth quarter worth $29,000. Kohmann Bosshard Financial Services LLC purchased a new stake in SPDR S&P Biotech ETF during the 4th quarter valued at about $29,000. Avior Wealth Management LLC raised its holdings in SPDR S&P Biotech ETF by 393.6% in the 4th quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock valued at $35,000 after acquiring an additional 307 shares during the last quarter. Lee Danner & Bass Inc. purchased a new position in SPDR S&P Biotech ETF in the 4th quarter worth approximately $38,000. Finally, Bank of Jackson Hole Trust acquired a new position in shares of SPDR S&P Biotech ETF during the 4th quarter worth approximately $43,000.

SPDR S&P Biotech ETF Stock Performance

Shares of SPDR S&P Biotech ETF stock opened at $84.40 on Friday. The business’s 50 day moving average price is $89.40 and its 200 day moving average price is $93.94. The company has a market cap of $5.47 billion, a price-to-earnings ratio of 11.47 and a beta of 0.99. SPDR S&P Biotech ETF has a one year low of $81.14 and a one year high of $105.47.

SPDR S&P Biotech ETF Cuts Dividend

The business also recently declared a dividend, which was paid on Wednesday, March 26th. Stockholders of record on Monday, March 24th were issued a dividend of $0.0053 per share. The ex-dividend date of this dividend was Monday, March 24th.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.